Lates News
During Thursday's analyst conference call, Eli Lilly CEO David Ricks expressed support for the Trump administration's push for a more equitable global sharing of pharmaceutical research and development costs, but warned that direct comparisons of different pricing systems may be "inaccurate and misleading."
Latest